Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB5 | P28074 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.31 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.31 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26569654 | 0.82 | KIF11 (0.42) | KDM4EALDH1A1MAPTNPSR1 | |
| SCHEMBL26569655 | 0.80 | PSMB5 (0.50) | PSMB5KDM4EALDH1A1MAPTTRPA1 | |
| SCHEMBL3481745 | 0.70 | NR1H2 (0.38) | NR1H2NR1H3 | |
| SCHEMBL5546191 | 0.67 | ACHE (0.35) | KDM4EALDH1A1MAPTNR1H2NR1H3 | |
| SCHEMBL25763024 | 0.66 | ACHE (0.34) | KDM4EALDH1A1MAPTNR1H2NR1H3 | |
| SCHEMBL26569683 | 0.66 | SMN1; SMN2 (0.38) | PSMB5ALDH1A1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL26569652 | 0.66 | HSP90AA1 (0.33) | — | |
| SCHEMBL19735232 | 0.65 | KIF11 (0.58) | KDM4EALDH1A1MAPTNR1H2NR1H3 | |
| SCHEMBL10997473 | 0.65 | NR1H2 (0.44) | ALDH1A1MAPTNR1H2NR1H3 | |
| SCHEMBL28308652 | 0.65 | NR1H2 (0.44) | ALDH1A1MAPTNR1H2NR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337517-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337517-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, OCIAD2, OCIAD1 | PSMB5 3497/4885KDM4E 3832/4885ALDH1A1 1442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.